| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.224 | 6.221 | 8.465 | 9.551 | 9.567 | 5.086 | 8.797 | 8.253 | 9.946 | 7.869 |
| Total Income - EUR | 5.224 | 6.221 | 8.465 | 9.551 | 9.567 | 5.086 | 8.797 | 8.253 | 9.946 | 7.869 |
| Total Expenses - EUR | 3.826 | 2.886 | 4.215 | 6.946 | 7.527 | 5.626 | 6.003 | 7.050 | 9.475 | 7.870 |
| Gross Profit/Loss - EUR | 1.398 | 3.335 | 4.250 | 2.605 | 2.040 | -540 | 2.793 | 1.203 | 471 | -1 |
| Net Profit/Loss - EUR | 1.241 | 3.273 | 4.165 | 2.318 | 1.753 | -693 | 2.530 | 955 | 396 | -1 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medfemme Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.927 | 12.851 | 10.761 |
| Current Assets | 13.596 | 16.720 | 20.646 | 22.639 | 24.042 | 22.890 | 24.914 | 238 | 846 | 2.919 |
| Inventories | 0 | 0 | 0 | 211 | 207 | 203 | 198 | 199 | 370 | 401 |
| Receivables | 12.225 | 16.453 | 20.166 | 19.796 | 23.281 | 22.327 | 23.453 | 0 | 2 | 3 |
| Cash | 1.371 | 267 | 479 | 2.632 | 554 | 360 | 1.263 | 39 | 474 | 2.515 |
| Shareholders Funds | 10.144 | 13.313 | 17.253 | 19.255 | 20.635 | 19.551 | 21.647 | 3.574 | 3.959 | 3.935 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 3.452 | 3.407 | 3.392 | 3.384 | 3.406 | 3.339 | 3.267 | 11.592 | 9.738 | 9.744 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medfemme Srl